Company Filing History:
Years Active: 2002-2010
Title: Simon L McGurk: Innovator in Bioadhesive Nanoparticulate Compositions
Introduction
Simon L McGurk is a notable inventor based in King of Prussia, PA (US). He has made significant contributions to the field of bioadhesive nanoparticulate compositions, holding a total of 4 patents. His work focuses on enhancing the interaction of nanoparticles with biological substrates, which has implications in various industries, including pharmaceuticals and agriculture.
Latest Patents
Among his latest patents is a groundbreaking invention titled "Bioadhesive nanoparticulate compositions having cationic surface stabilizers." This patent describes compositions that include active agent particles and cationic surface stabilizers, which prevent aggregation of nanoparticles and enhance their bioadhesion to various biological substrates. These substrates can include insects, teeth, bones, and plant tissues, among others. The active agent particles may consist of pharmacologically active compounds, agricultural chemicals, cosmetic agents, or other materials that interact with biological substrates. Additionally, McGurk has developed a patent for "Gel stabilized nanoparticulate active agent compositions," which details a dosage form that combines nanoparticulate active agents with gel-forming substances. This innovation allows for easy administration and rapid dissolution of the active agent.
Career Highlights
Simon L McGurk is currently associated with Elan Pharma International Limited, where he continues to innovate in the field of nanoparticulate compositions. His work has been instrumental in advancing the understanding and application of bioadhesive technologies.
Collaborations
Some of his notable coworkers include H William Bosch and Eugene Rex Cooper, who have collaborated with him on various projects within the realm of bioadhesive technologies.
Conclusion
Simon L McGurk's contributions to the field of bioadhesive nanoparticulate compositions highlight his innovative spirit and dedication to advancing technology. His patents reflect a commitment to improving the efficacy of active agents in various applications, making a significant impact in multiple industries.